Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific begins WallFlex trial

This article was originally published in Clinica

Executive Summary

A clinical trial to evaluate temporary implantation of Boston Scientific's fully-covered WallFlex biliary stent in the treatment of benign bile duct strictures has been initiated. The 187-patient trial will evaluate the effectiveness of temporary stenting for treating long-term benign biliary strictures, as well as their removal. The study will include patients with bile duct strictures associated with post-liver transplant anastomosis, prior abdominal surgery such as gall bladder removal, and chronic pancreatitis. The stent will remain in the patients for 4-12 months depending on the nature of the stricture, and patients will be followed for five years after stent removal.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT045257

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel